Cargando…
Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres
There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deplo...
Autores principales: | MacLean, Emily Lai-Ho, Miotto, Paolo, González Angulo, Lice, Chiacchiaretta, Matteo, Walker, Timothy M., Casenghi, Martina, Rodrigues, Camilla, Rodwell, Timothy C., Supply, Philip, André, Emmanuel, Kohli, Mikashmi, Ruhwald, Morten, Cirillo, Daniela Maria, Ismail, Nazir, Zignol, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065236/ https://www.ncbi.nlm.nih.gov/pubmed/37000774 http://dx.doi.org/10.1371/journal.pgph.0001754 |
Ejemplares similares
-
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex
por: Tornheim, Jeffrey A, et al.
Publicado: (2019) -
Designing molecular diagnostics for current tuberculosis drug regimens
por: Georghiou, Sophia B., et al.
Publicado: (2023) -
Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review
por: Bigio, Jacob, et al.
Publicado: (2021) -
Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis
por: Zimmer, Alexandra J., et al.
Publicado: (2022) -
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
por: Mirzayev, Fuad, et al.
Publicado: (2021)